Arthritis Northwest, PLLC

Spokane, Washington 99216

0 studies enrolling now · 34 studies all time

What they study most

Ankylosing Spondylitis, Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, Axial Spondyloarthritis, Chronic Gout, Chronic Hypoparathyroidism, Connective Tissue Diseases, Endocrine System Diseases, Gout, Gout Flare, Hyperuricemia

Studies at this site

• The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis — Completed
• A Study of Baricitinib in Participants With Rheumatoid Arthritis — Completed
• A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome — Running, not enrolling
• A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus — Completed
• A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL) — Completed
• Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight — Completed
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis — Stopped early
• Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism — Running, not enrolling
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis — Completed
• Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout — Completed
• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease — Completed
• An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed
• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis — Completed
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) — Completed
• Tanezumab in Osteoarthritis of the Hip or Knee (2) — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis — Completed
• Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care — Status unconfirmed
• An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate — Completed
• BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3) — Completed
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis — Completed
• Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis — Completed
• Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab — Completed
• Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout — Completed
• Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout — Completed
• Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate — Stopped early
• Study of LJP 394 in Lupus Patients With History of Renal Disease — Stopped early